Inventors:
James M. Tour - Bellaire TX, US
Jacob Berlin - Monrovia CA, US
Tam Pham - Renton WA, US
Jeffrey N. Myers - Bellaire TX, US
Daisuke Sano - Yokohama, JP
Assignee:
William Marsh Rice University - Houston TX
International Classification:
A61K 47/18, A61K 31/711, A61K 31/7088, A61K 31/713, A61K 31/7105, A61K 31/337, A61K 31/05, A61K 39/395, A61K 31/195, A61K 9/14, A61K 47/04, A61K 47/26, A61K 47/42, A61P 35/00, A61P 31/00, A61P 39/06, A61P 29/00, A61N 5/00, A61K 38/02, B82Y 5/00, B82Y 40/00
US Classification:
600 1, 514 11, 514 44 R, 514 44 A, 514449, 514731, 4241301, 4241411, 4241381, 4241331, 514784, 514563, 424400, 514769, 514777, 514773, 977750, 977746, 977734, 977906, 977842
Abstract:
The present invention pertains to therapeutic compositions that comprise: (1) a nanovector, (2) an active agent; and (3) a targeting agent, wherein the active agent and the targeting agent are non-covalently associated with the nanovector. The present invention also pertains to methods of treating various conditions in a subject by utilizing the above-described therapeutic compositions. Methods of making the therapeutic compositions are also a subject matter the present invention.